Skip to main content

MoneyWorks4Me

Lupin informs about press release

30 Jul 2021 Evaluate

In compliance with Regulation 30 read with Schedule III of the Listing Regulations and SEBI Circular CIR/CFD/CMD/4/2015 dated September 9, 2015, Lupin has informed that it attached a Press Release on 30th July 2021 regarding acquisition of Southern Cross Pharma, Australia.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1778.25
Dr. Reddys Labs. 1350.20
Cipla 1380.00
Lupin 2009.00
Zydus Lifesciences 1244.00
View more..